Dendritic cell‐based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model

BACKGROUND: Tumour‐specific cytotoxic T lymphocytes (CTLs) can be activated in vivo by vaccination with dendritic cells (DCs). However, clinical responses to DC‐based vaccination have only been observed in a minority of patients with solid cancer. Combination with other treatment modalities such as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bauer, C, Bauernfeind, F, Sterzik, A, Orban, M, Schnurr, M, Lehr, H A, Endres, S, Eigler, A, Dauer, M
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2007
Assuntos:
Pancreatic Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954993/
https://ncbi.nlm.nih.gov/pubmed/17395611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2006.108621
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares